NEUROSHIELD
NeuroShield is made of naturally occurring Chitosan, which shields nerves from further damage and promotes faster regrowth. It is indicated for the repair of peripheral nerve injuries in which there is no gap or where a gap closure can be achieved by flexion of the extremity.
NEUROSHIELD
Industry:
Health Care Medical Device Therapeutics
Founded:
2016-01-01
Address:
Platz, Graubunden, Switzerland
Country:
Switzerland
Website Url:
http://www.monarchbioimplants.com
Status:
Active
Contact:
+41 (0)41 4552260
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Euro Amazon
Similar Organizations
Jongsma Medical
Jongsma Medical specializes in offering advisory and medical aids services for contact lenses, therapeutic glasses and visual impairment.
Recornea
Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea.
Vilex
Vilex is a manufacturing company that produces hintermann ankle, Hemi, subtalar, plates, screws, and medical devices for orthopedic surgery.
Current Employees Featured
Official Site Inspections
http://www.monarchbioimplants.com Semrush global rank: 10.06 M Semrush visits lastest month: 55
Unable to get host informations!!!
More informations about "NeuroShield"
Monarch Bioimplants - Crunchbase Company Profile
Monarch Bioimplants is a a biomedical company, that develops solutions for prostate cancer treatment.See details»
Monarch Bioimplants - Overview, News & Competitors - ZoomInfo
View Monarch Bioimplants (www.monarchbioimplants.com) location in Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Monarch Bioimplants - Company Profile - Tracxn
Oct 22, 2024 Monarch Bioimplants - Developer of bioimplant for peripheral nerve repair. Raised a total funding of $24.9M over 2 rounds from 2 investors. Founded by Rivelino Montenegro …See details»
Monarch Bioimplants - Products, Competitors, Financials, …
Monarchbioimplants.com. Overview & Products; Financials; People; Stage Series A | Alive. Total Raised $24.96M. Last Raised $23.45M | 4 yrs ago. About Monarch Bioimplants. Monarch …See details»
MONARCH BIOIMPLANTS LTD - Overview (free company …
Confirmation statement. Next statement date 10 September 2021 due by 24 September 2021. Last statement dated 10 September 2020See details»
Monarch Bioimplants GmbH Asset Profile | Preqin
Founded in 2016 and based in Root, Switzerland, Monarch Bioimplants GmbH engages in the development of Neuroshield, a chitosan membrane that helps repair ner...See details»
Monarch Bioimplants GmbH - startupticker.ch
More news about Monarch Bioimplants GmbH. 13.08.2021 12:10. Monarch BioImplants’ assets acquired by US companySee details»
NeuroShield’s Competitors, Revenue, Number of Employees
NeuroShield’s Profile, Revenue and Employees. Monarch Bioimplants is a biotech company that researches and develops chitosan-based bioimplants.See details»
Monarch Bioimplants FDA Filings
Monarch Bioimplants FDA Filings. This page includes the latest FDA filings for Monarch Bioimplants. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket …See details»
Monarch Bioimplants GmbH - startupticker.ch
Sep 30, 2020 The legal guide for startups: Save time and money with the best solution to create, manage, and sign legal documentsSee details»
Monarch Bioimplants GmbH - startup.ch
Monarch Bioimplants GmbH: NeuroShield is made of naturally occurring Chitosan, which shields nerves from further damage and promotes faster regrowth. This accelerates recovery from …See details»
Monarch Bioimplants Stock Price, Funding, Valuation, Revenue ...
See Monarch Bioimplants funding rounds, investors, investments, exits and more. Evaluate their financials based on Monarch Bioimplants's post-money valuation and revenue.See details»
Monarch Bioimplants CEO, Founder, Key Executive Team, Board of ...
Explore {Monarch Bioimplants's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Monarch Bioimplants Secures €20 Million from GEM Global Yield LLC
Sep 28, 2020 Investment supports development of promising biosynthetic nerve repair technology, NeuroShieldTMROOT, SWITZERLAND / ACCESSWIRE / September 28, 2020 / …See details»
Monarch Bioimplants secures record investment at Technopark …
Monarch Bioimplants, a startup from Technopark Lucerne, is receiving 20 Million euro over the next 36 months from New York investment group GEM. The GEM Group with branches in …See details»
Monarch Bioimplants Culture | Comparably
Learn about Monarch Bioimplants' culture, see what work's like, read reviews, and find job opportunities.See details»
Monarch Bioimplants Secures €20 Million from GEM Global Yield LLC
Sep 28, 2020 Investment supports development of promising biosynthetic nerve repair technology, NeuroShield TM. ROOT, SWITZERLAND / ACCESSWIRE / September 28, 2020 / …See details»
Monarch Bioimplants secures €20 million for its nerve …
Sep 30, 2020 Register and get more services Create your personal archive Get the Newsletter Set award alarms. Get involvedSee details»
Monarch Biosciences Company Profile 2024: Valuation, Funding ...
Monarch Biosciences General Information Description. Developer of a medical device designed to offer cell therapies to treat solid tumors. The company's devices offer rapid occlusion of …See details»
NeuroShield - Crunchbase Company Profile & Funding
NeuroShield is made of naturally occurring Chitosan, which shields nerves from further damage and promotes faster regrowth. It is indicated for the repair of peripheral nerve injuries in which …See details»